(19)

(11)

EP 4 816 023 A1

(12)

(43) Date of publication: 07.10.2026 Bulletin 2026/41 (21) Application number: 24813167.4 (22) Date of filing: 26.11.2024

(51) International Patent Classification (IPC):  A61M 5/20(2006.01) A61M 5/315(2006.01) A61M 5/24(2006.01) (52) Cooperative Patent Classification (CPC): A61M 5/31553; A61M 5/31543; A61M 5/31541; A61M 5/31583; A61M 5/20; A61M 5/24 (86) International application number: PCT/EP2024/083563 (87) International publication number: WO 2025/114259 (05.06.2025 Gazette 2025/23)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 28.11.2023 EP 23212595 09.02.2024 EP 24156802 (71) Applicant: Novo Nordisk A/S 2880 Bagsværd (DK)	(72) Inventors: LARSEN, Bjørn Gullak 2880 Bagsværd (DK) BRUUN-JESPERSEN, Mikkel Oliver 2880 Bagsværd (DK) PEDERSEN, Bennie Peder Smiszek 2880 Bagsværd (DK)